Borderline Hypertension
Conditions
Interventions
Experimental group:Ershu Tianma Granules 1 dose,2/d
Control group:Ershu Tianma placebo Granules 1 dose,2/d
Sponsors
Eye Hospital of China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: ?No antihypertensive medication in the last 4 weeks and three consecutive upper limb brachial artery sitting blood pressure measurements on non-same day within 1 week, systolic blood pressure (SBP) 120-139 mmHg and/or diastolic blood pressure (DBP) 80-89 mmHg. ?Age 18-65 years old, gender not limited. ?Meet the diagnostic criteria of phlegm-dampness internal obstruction evidence. ?Voluntary participation and cooperation with the investigator by signing the written informed consent.
Exclusion criteria
Exclusion criteria: ?People with definite primary and secondary hypertension. ?Participating in other clinical researchers. ?People with borderline hypertension who are taking western antihypertensive drugs. ?People with acute coronary syndrome, acute attack of chronic heart failure, malignant arrhythmia, heart valve disease, cardiomyopathy and other serious cardiovascular diseases. ?People with acute or severe cerebrovascular diseases such as cerebral hemorrhage, subarachnoid hemorrhage, cerebral infarction and transient ischemic attack. ?People with severe liver or kidney dysfunction and conditions judged by the investigator to be inappropriate for enrollment. ?Pregnant and lactating women. ?Allergic or allergic to multiple drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Consulting room blood pressure; | — |
Secondary
| Measure | Time frame |
|---|---|
| Body mass index;Waist Circumference;Homocysteine;Home Self-Test Blood Pressure;Uric Acid;Chinese medicine evidence score;Fasting blood sugar;Ambulatory blood pressure mean blood pressure values;Ambulatory blood pressure load values and circadian rhythms;C-reactive protein;Serum lipid level;Quality of life; | — |
Countries
China
Contacts
Public ContactYao Kuiwu
Eye Hospital of China Academy of Chinese Medical Sciences
Outcome results
None listed